 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Thomas Jefferson University and VelaDx to Develop NGS-Based Tests for Oncology, Infectious Disease
February 06, 2013
Thomas Jefferson University and VelaDx to Develop NGS-Based Tests for Oncology, Infectious Disease
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- VelaDx to Develop Oncology and Infectious Disease Tests on the Ion Torrent PGM
October 10, 2012 / Clinical Sequencing News - Industry Observers Question Myriad's Competitive Advantage as It Looks to Launch NGS Cancer Panel
May 22, 2013 / Clinical Sequencing News - New Products: Inex Innovations Exchange's iGeneScreen
May 22, 2013 / Clinical Sequencing News - People in the News: Charles Lee
May 22, 2013 / Clinical Sequencing News - Debate Heats Up on ACMG's Incidental Findings Recommendations
May 20, 2013 / Clinical Sequencing News